Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid.
Bioinformation
; 18(3): 170-179, 2022.
Article
in English
| MEDLINE | ID: covidwho-2164132
ABSTRACT
It is of interest to document the Molecular Dynamics Simulation and docking analysis of NF-κB target with sulindac sodium in combating COVID-19 for further consideration. Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) of the arylalkanoic acid class that is marketed by Merck under the brand name Clinoril. We show the binding features of sulindac sodium with NF-κB that can be useful in drug repurposing in COVID-19 therapy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Bioinformation
Year:
2022
Document Type:
Article
Affiliation country:
97320630018170
Similar
MEDLINE
...
LILACS
LIS